Hypertensive nephropathy medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
s |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hypertensive nephropathy}} | {{Hypertensive nephropathy}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
==Medical therapy== | {{CMG}}{{AE}}{{NN}} | ||
* | |||
** [[ACE inhibitors]] | |||
** [[Diuretics]] | ==Medical therapy<ref name="PughGallacher2019">{{cite journal|last1=Pugh|first1=Dan|last2=Gallacher|first2=Peter J.|last3=Dhaun|first3=Neeraj|title=Management of Hypertension in Chronic Kidney Disease|journal=Drugs|volume=79|issue=4|year=2019|pages=365–379|issn=0012-6667|doi=10.1007/s40265-019-1064-1}}</ref>== | ||
* Non-pharmacological therapy | |||
**Lifestyle modification and decreased salt intake | |||
***Sodium intake < 50 mmol/day (3 g/day of salt) leads to reduce systolic blood pressure by 10 mmHg. | |||
*** Sodium intake< 100 mmol/day (6 g/day of salt) has been found to decrease proteinuria by 25%. | |||
**Weight loss | |||
* Pharmacological therapy to control hypertension includes: | |||
** [[ACE inhibitors]] or ARB | |||
** [[Diuretics]]: [[loop diuretics]] and [[thiazides]] | |||
** [[Calcium channel blockers]] | |||
** [[Beta blockers]] | ** [[Beta blockers]] | ||
** [[ | ** [[Alpha blockers]] | ||
** [[ | ** [[Mineralocorticoid receptor blockers]] | ||
** [[Renin | ** [[Renin]] inhibitors | ||
==References== | ==References== | ||
| Line 21: | Line 33: | ||
[[Category:Kidney diseases]] | [[Category:Kidney diseases]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Nephrology]] | |||
[[Category:Needs overview]] | |||
Latest revision as of 00:17, 15 June 2020
|
Hypertensive nephropathy Microchapters |
|
Differentiating Hypertensive Nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertensive nephropathy medical therapy On the Web |
|
American Roentgen Ray Society Images of Hypertensive nephropathy medical therapy |
|
Risk calculators and risk factors for Hypertensive nephropathy medical therapy |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
Medical therapy[1]
- Non-pharmacological therapy
- Lifestyle modification and decreased salt intake
- Sodium intake < 50 mmol/day (3 g/day of salt) leads to reduce systolic blood pressure by 10 mmHg.
- Sodium intake< 100 mmol/day (6 g/day of salt) has been found to decrease proteinuria by 25%.
- Weight loss
- Lifestyle modification and decreased salt intake
- Pharmacological therapy to control hypertension includes:
References
- ↑ Pugh, Dan; Gallacher, Peter J.; Dhaun, Neeraj (2019). "Management of Hypertension in Chronic Kidney Disease". Drugs. 79 (4): 365–379. doi:10.1007/s40265-019-1064-1. ISSN 0012-6667.